CIAN Diagnostics is a biotechnology and healthcare startup based in the United States, founded in 2013. The company's slogan, "Your Solution for accurate & reliable COVID-19 testing," reflects its primary focus on diagnostic, toxicology, molecular/genetic testing, and laboratory services. The locally owned and operated laboratory serves DC, Virginia & Maryland, standing out with its brand new facility equipped with state-of-the-art equipment and a team of experienced lab specialists and technicians. The company is backed by medical physicians with over 20 years of experience in the field, and its medical director has over 25 years of laboratory experience within the DoD. CIAN Diagnostics presents a promising opportunity for venture capitalists seeking to invest in the biotechnology and healthcare industries. With its strong emphasis on reliable COVID-19 testing solutions and a comprehensive range of diagnostic services, the company has the potential to address critical healthcare needs. While the specific details about the company's last investment and the involved investors are currently unavailable, the innovative approach and the experienced team behind CIAN Diagnostics make it a noteworthy contender for investment consideration in the life sciences sector.
There is no investment information
No recent news or press coverage available for CIAN Diagnostics.